AMERIGEN

What this means for you

This application is over — abandoned 02 Mar 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

86956277

Mark type

Stylized text

Filed

29 Mar 2016

Published for opposition

06 Dec 2016

Abandoned

02 Mar 2020

Attorney of record

Karl M. Zielaznicki,

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of hypertension, depression, cardiovascular disease, allergies, neurological disorders, gastro-intestinal disease, urinary incontinence, Parkinson's disease, Alzheimer's disease, oncology, diabetes and metabolic disorders, dermatological disorders, bipolar disorder and schizophrenia, vitamin D deficiency, bleeding disorders, BPH or benign prostatic hyperplasia, erectile dysfunction and pain, women's health issues relating to birth control, menstruation, menopause, breast health and disorders, sexual health and disorders, female reproductive health and disorders, pregnancy and autoimmune diseases

Owner

• Amerigen Pharmaceuticals, Ltd., KY1-1111, KY
• Amerigen Pharmaceuticals, Ltd., KY1-1111, KY

Prosecution history

• 02 Mar 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 02 Mar 2020 — ABANDONMENT - NO USE STATEMENT FILED
• 22 Jan 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
• 04 Jul 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 03 Jul 2019 — SOU EXTENSION 5 GRANTED
• 01 Jul 2019 — SOU EXTENSION 5 FILED
• 03 Jul 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 01 Jul 2019 — SOU TEAS EXTENSION RECEIVED
• 14 Dec 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 12 Dec 2018 — SOU EXTENSION 4 GRANTED
• 12 Dec 2018 — SOU EXTENSION 4 FILED
• 12 Dec 2018 — SOU TEAS EXTENSION RECEIVED
• 07 Jun 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 05 Jun 2018 — SOU EXTENSION 3 GRANTED
• 05 Jun 2018 — SOU EXTENSION 3 FILED